COVID-19
13Prevention
- 2015.01 - The Omega-3 Fatty Acid Docosahexaenoic Acid ModulatesInflammatory Mediator Release in Human Alveolar Cells Exposed to Bronchoalveolar Lavage Fluid of ARDS Patients.pdf
- 2019.05 - Omega-3 polyunsaturated fatty acids in critically illpatients with acute respiratory distress syndrome - A systematic review and meta-analysis.pdf
- 2020.02 - Potential interventions for novel coronavirus in China - A systematic review.pdf
- 2020.03 - Can Bioactive Lipids Inactivate Coronavirus (COVID-19).pdf
- 2020.03 - ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.pdf
- 2020.03 - Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19).pdf
- 2020.04 - COVID-19 and vitamin D—Is there a link and an opportunity for intervention.pdf
- 2020.04.02 - Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.pdf
- 2020.04.03 - Optimisation of Vitamin D status for enhanced immune-protection against Covid-19.pdf
- 2020.04.03 - Virtual screening and repurposing of FDA approved drugs against COVID-19 T main protease.pdf
- 2020.04.21 - COVID-19 - Potential of Microalgae Derived NaturalAstaxanthin As Adjunctive Supplement in Alleviating Cytokine Storm.pdf
- 2020.04.23 - Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections.pdf
- 2020.04.23 - Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-19).pdf
